Taurolidine Lock in Long Term Parenteral Nutrition

Phase 4CompletedNCT02009189

Stanley Dudrick's Memorial Hospital30 enrolled

Overview

Taurolidine alone or in combination with citrate have been proposed for locking the catheter to reduce the number of catheter infections. As there is not enough evidence to give recommendations in this regard, the study tested the hipothesis that taurolidine improves the outcome of long term paretneral nutrition.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Enrollment

Conditions

Home Parenteral Nutrition Central Venous Catheter

Interventions

2% Taurolidine LockDRUG

Catheter lock with 2% Taurolidine

1.35% TaurolidineDRUG

Catheter lock with 1.35% Taurolidine + citrate

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * home parenteral nutrition for at least months before enrollment * presence of central venous cathter Exclusion Criteria: * home nutrition \< 12 months * catheter in peripheral vein

Locations (1)

Stanley Dudrick's Memorial Hospital

Skawina, Poland

Outcomes

Primary Outcomes

Number of CVC infections

Number of central venous catheter infections

Time frame: 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.